Article
Plasma acylation-stimulating protein in coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology - 1 Jul 1997
Cianflone K, Zhang X J, Genest J, Sniderman A
Abstract excerpt
To date, plasma levels of acylation-stimulating protein (ASP) have been determined only in normal and obese individuals. Accordingly. ASP was measured in fasting samples obtained from 59 age-matched controls and 208 patients with documented coronary artery disease (CAD). Overall, plasma ASP was significantly higher in the CAD subjects compared to the control subjects (55.3 +/- 1.8 nmol/L CAD versus 32.0 +/- 2.6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.